Table 1 Description of selected characteristics, screening test positivity and biopsies taken among study participants by study site
From: Different cervical cancer screening approaches in a Chinese multicentre study
Shanxi | Liaoning | Guangdong | All | |
|---|---|---|---|---|
N (%) | N (%) | N (%) | N (%) | |
Total | 743 (100) | 699 (100) | 1120 (100) | 2562 (100) |
Selected characteristics | ||||
Age group (years) | ||||
15–29 | 147 (19.8) | 121 (17.3) | 348 (31.1) | 616 (24.0) |
30–39 | 198 (26.7) | 193 (27.6) | 384 (34.3) | 775 (30.3) |
40–49 | 197 (26.5) | 191 (27.3) | 295 (26.3) | 683 (26.7) |
50–59 | 201 (27.1) | 194 (27.8) | 93 (8.3) | 488 (19.1) |
Secondary education | 86 (11.6) | 317 (45.4) | 895 (79.9) | 1298 (50.7) |
Unmarried | 26 (3.5) | 76 (10.9) | 151 (13.5) | 253 (9.9) |
>1 lifetime sexual partner | 129 (17.4) | 117 (16.7) | 167 (14.9) | 413 (16.1) |
Pap smear history | 68 (9.2) | 45 (6.4) | 232 (20.7) | 345 (13.5) |
Screening test outcomes | ||||
VIA positive | Not assessable | 65 (9.3) | 142 (12.7) | 207 (11.4) |
Colposcopy positive | 165 (22.2) | 105 (15.0) | 146 (13.0) | 416 (16.2) |
LBC⩾ASCUS positive | 138 (18.6) | 76 (10.9) | 225 (20.1) | 439 (17.1) |
HC2 positive | 119 (16.0) | 144 (20.6) | 155 (13.8) | 418 (16.3) |
Biopsies taken | 301 (40.5) | 232 (33.2) | 120 (10.7) | 653 (25.5) |
